No black box warning on record for Excedrin Pm Triple Action Caplets

As of the latest FDA labeling reviewed, Excedrin Pm Triple Action Caplets (ACETAMINOPHEN, ASPIRIN (NSAID) AND DIPHENHYDRAMINE CITRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Excedrin Pm Triple Action Caplets medicine page for the complete safety profile.

Other warnings & precautions

Warnings Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness. Allergy alert: Acetaminophen may cause severe skin reactions. Symp

No black box warning on record for Excedrin Pm Triple Action Caplets

Other warnings & precautions

Warnings Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness. Allergy alert: Acetaminophen may cause severe skin reactions. Symp

Excedrin Pm Triple Action Caplets Black Box Warning

No black box warning on record for Excedrin Pm Triple Action Caplets

Other warnings & precautions

Excedrin Pm Triple Action Caplets Black Box Warning

No black box warning on record for Excedrin Pm Triple Action Caplets

Other warnings & precautions